30-Apr-2021 07:43 AM
Pharmaceuticals group Hikma Pharmaceuticals forecast its generics business to generate revenue toward the top end of guidance following a 'good' start to the new year that was in line with its expectations.
Full year generics revenue was now e
25-Feb-2021 08:16 AM
Pharmaceutical company Hikma Pharmaceuticals reported a rise in profit led by growth in its injectables business.
For the year ended 31 December 2020, pre-tax profit rose to $558 million from $491 million last year and revenue to rise 6% to $2.34 bill
05-Nov-2020 08:05 AM
Hikma Pharmaceuticals lifted its full-year guidance on revenue for its generics segment following stronger-than-expected performance in the year to date.
Revenue for generics was lifted to a range of $720 million to $740 million, from previous guidance r
04-Sep-2020 08:20 AM
Barclays Capital today upgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to overweight (from equal weight) and raised its price target to 2800p (from 2350p).
Story provided by StockMarketWire.com
Broker Forecasts data provided by www
14-Aug-2020 09:20 AM
Barclays Capital today reaffirms its equal weight investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 2350p (from 2200p).
Story provided by StockMarketWire.com
Broker Forecasts data provided by www.sharesmagazine.co.u
07-Aug-2020 07:35 AM
Generic pharmaceuticals company Hikma Pharmaceuticals upgraded its outlook on its injectable business after first-half results came in ahead of its expectations on increased demand for Covid-19-related products.
For the six months ended 30 June, pre-tax
30-Jul-2020 08:30 AM
Peel Hunt today reaffirms its buy investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 2860p (from 2380p).
Story provided by StockMarketWire.com
Broker Forecasts data provided by www.sharesmagazine.co.uk...
07-Jul-2020 11:00 AM
Morgan Stanley today upgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to overweight (from equal weight) and raised its price target to 2600p (from 2200p).
Story provided by StockMarketWire.com
Broker Forecasts data provided by www.s
30-Apr-2020 07:45 AM
Hikma Pharmaceuticals maintained its guidance and said it had made a 'strong start' to the year despite the challenging market conditions owing to the Covid-19 crisis.
The company reiterating its guidance for global injectables revenue growth
28-Apr-2020 11:30 AM
Barclays Capital today reaffirms its equal weight investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 2200p (from 1950p).
Story provided by StockMarketWire.com
Broker Forecasts data provided by www.sharesmagazine.co.u
24-Apr-2020 10:40 AM
Goldman Sachs today downgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to neutral (from buy) and raised its price target to 2400p (from 2200p).
Story provided by StockMarketWire.com
Broker Forecasts data provided by www.sharesmagaz
07-Apr-2020 10:30 AM
Peel Hunt today upgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to buy (from buy).
Story provided by StockMarketWire.com
Broker Forecasts data provided by www.sharesmagazine.co.uk...
03-Apr-2020 09:50 AM
Citigroup today reaffirms its buy investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 2500p (from 2150p).
Story provided by StockMarketWire.com
Broker Forecasts data provided by www.sharesmagazine.co.uk...
02-Apr-2020 10:20 AM
Peel Hunt today upgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to buy (from hold) and raised its price target to 2380p (from 1990p).
Story provided by StockMarketWire.com
Broker Forecasts data provided by www.sharesmagazine.co.uk.
31-Mar-2020 09:00 AM
Generic pharmaceutical company Hikma Pharmaceuticals said a U.S. ruled that patents covering Amarin's heart drug were invalid, paving the way for the company to sell generic versions of the drug.
Hikma said it was working closely with the U.S. Food
12-Mar-2020 12:50 PM
Jefferies International today reaffirms its buy investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 2390p (from 2300p).
Story provided by StockMarketWire.com
Broker Forecasts data provided by www.sharesmagazine.co.uk.
10-Mar-2020 12:50 PM
Citigroup today upgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to buy (from neutral) and raised its price target to 2150p (from 1980p).
Story provided by StockMarketWire.com
Broker Forecasts data provided by www.sharesmagazine.co.
02-Mar-2020 01:50 PM
Barclays Capital today reaffirms its equal weight investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 1950p (from 1900p).
Story provided by StockMarketWire.com
Broker Forecasts data provided by www.sharesmagazine.co.u
27-Feb-2020 09:24 AM
Hikma Pharmaceuticals reported a rise in profit as cost cuts and higher revenue underpinned performance.
For the year ended 31 December 2019, pre-tax profit rose to £49m1 from £293m on-year as revenue climbed 7% to £2.2bn.
The inject
17-Feb-2020 10:10 AM
Citigroup today downgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to neutral (from buy).
Story provided by StockMarketWire.com
Broker Forecasts data provided by www.sharesmagazine.co.uk...
21-Jan-2020 10:30 AM
Jefferies International today reaffirms its buy investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and cut its price target to 2240p (from 2310p).
Story provided by StockMarketWire.com
Broker Forecasts data provided by www.sharesmagazine.co.uk...
06-Jan-2020 10:40 AM
JP Morgan Cazenove today downgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to underweight (from neutral) and raised its price target to 1850p (from 1800p).
Story provided by StockMarketWire.com
Broker Forecasts data provided by ww
03-Dec-2019 10:10 AM
JP Morgan Cazenove today reaffirms its neutral investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 1800p (from 1700p).
Story provided by StockMarketWire.com
Broker Forecasts data provided by www.sharesmagazine.co.uk..
07-Nov-2019 07:16 AM
Hikma Pharmaceuticals said it expected revenues in its generics business to be closer to the top end of its guidance range following strong demand and operational improvements.
For the full year, the pharma company said it now expected generics revenue
20-Aug-2019 08:40 AM
Barclays Capital today reaffirms its equal weight investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 1900p (from 1800p).
Story provided by StockMarketWire.com
Broker Forecasts data provided by www.sharesmagazine.co.u